These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19208103)

  • 1. Germinal mosaicism in MYH9 disorders: a family with two affected siblings of normal parents.
    Kunishima S; Takaki K; Ito Y; Saito H
    Br J Haematol; 2009 Apr; 145(2):260-2. PubMed ID: 19208103
    [No Abstract]   [Full Text] [Related]  

  • 2. First description of somatic mosaicism in MYH9 disorders.
    Kunishima S; Matsushita T; Yoshihara T; Nakase Y; Yokoi K; Hamaguchi M; Saito H
    Br J Haematol; 2005 Feb; 128(3):360-5. PubMed ID: 15667538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic and genetic characterization of an MYH9-related disorder in a Chinese family.
    Ma ES; Wong CL; Shek TW; Hui SP
    Haematologica; 2006 Jul; 91(7):1002-3. PubMed ID: 16818291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of MYH9 disorders presenting with macrothrombocytopenia and deafness caused by MYH9-R702C mutation.
    Kodama R; Taketani T; Kunishima S; Mishima S; Yoshikawa Y; Kanai R; Suyama T; Yoshino I; Kunishi H; Shibata H; Nagai A; Yamaguchi S; Masuda J
    Thromb Res; 2009 Sep; 124(4):508-11. PubMed ID: 19250658
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatic mosaicism in MYH9 disorders: the need to carefully evaluate apparently healthy parents.
    Kunishima S; Kitamura K; Matsumoto T; Sekine T; Saito H
    Br J Haematol; 2014 Jun; 165(6):885-7. PubMed ID: 24611568
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombocytopenia and proteinuria. Nonmuscle myosin heavy-chain-9-related disease ( MYH9 RD) or Epstein syndrome (ES).
    Bhatt A; Broxson E; Witte D; Omoloja A
    Pediatr Nephrol; 2009 Mar; 24(3):485-8. PubMed ID: 18781340
    [No Abstract]   [Full Text] [Related]  

  • 7. Description of a novel mutation leading to MYH9-related disease.
    Burt RA; Joseph JE; Milliken S; Collinge JE; Kile BT
    Thromb Res; 2008; 122(6):861-3. PubMed ID: 18676005
    [No Abstract]   [Full Text] [Related]  

  • 8. [Identification of MYH9 gene mutation in a May-Hegglin anomaly family].
    Gao F; Hao JH; Wang ZL
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):660-2. PubMed ID: 23134864
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a novel MYH9 mutation in a patient with May-Hegglin anomaly.
    Otsubo K; Kanegane H; Nomura K; Ogawa J; Miyawaki T; Kunishima S
    Pediatr Blood Cancer; 2006 Dec; 47(7):968-9. PubMed ID: 16642488
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in the understanding of MYH9 disorders.
    Kunishima S; Saito H
    Curr Opin Hematol; 2010 Sep; 17(5):405-10. PubMed ID: 20601875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of MYH9 mRNA at leukocyte inclusion bodies in MYH9 disorders.
    Kunishima S; Hirano K; Hamaguchi M; Saito H
    Eur J Haematol; 2008 Oct; 81(4):325-6. PubMed ID: 18616507
    [No Abstract]   [Full Text] [Related]  

  • 12. [A non-familial May-Hegglin anomaly accompanying with MYH9 gene R1933X mutation and I1626V polymorphism].
    Li Y; Wang YW; Zhang GS; Fang MY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):577-81. PubMed ID: 19954613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of the first large deletion of the MYH9 gene associated with MYH9 disorders.
    Kunishima S; Matsushita T; Hamaguchi M; Saito H
    Eur J Haematol; 2008 Jun; 80(6):540-4. PubMed ID: 18284620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
    Kunishima S
    Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation.
    Pecci A; Malara A; Badalucco S; Bozzi V; Torti M; Balduini CL; Balduini A
    Thromb Haemost; 2009 Jul; 102(1):90-6. PubMed ID: 19572073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families.
    Yi Y; Sen Zhang G; Xu M; San Ling Z; Ru Shao X; Zeng Li J; Ma J
    Clin Chim Acta; 2006 Nov; 373(1-2):49-54. PubMed ID: 16806139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early diagnosis improves the quality of life in MYH9 disorder.
    Shiota M; Kunishima S; Hamabata T; Nakata M; Hata D
    Pediatr Blood Cancer; 2012 Feb; 58(2):314-5. PubMed ID: 21796764
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of the first in cis mutations in MYH9 disorder.
    Miyajima Y; Kunishima S
    Eur J Haematol; 2009 Apr; 82(4):288-91. PubMed ID: 19191864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.
    Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R
    Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant platelet syndromes and the MYH9 mutations.
    Balduini CL
    Lab Hematol; 2004; 10(3):187-8. PubMed ID: 15529446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.